Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit

JACC: Heart Failure

Volumn 4, Issue 1, 2016, Pages 1-8

  Buckley, Leo F ^a   Carter, Danielle M ^a   Matta, Lina ^a   Cheng, Judy W ^b   Stevens, Craig ^a   Belenkiy, Roman M ^a   Burpee, Laura J ^a   Young, Michelle A ^a   Weiffenbach, Cynthia S ^a   Smallwood, Jennifer A ^a   Stevenson, Lynne W ^a   Desai, Akshay S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Ambulatory treatment; Heart failure; Loop diuretics

Indexed keywords

FUROSEMIDE; LOOP DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DIURETIC THERAPY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERVOLEMIA; HYPOKALEMIA; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; URINE VOLUME; WEIGHT REDUCTION; AMBULATORY CARE; DOSE RESPONSE; HEART STROKE VOLUME; HEART VOLUME; HYPEREMIA; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATIENT CARE; PHYSIOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; CARDIAC VOLUME; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT CARE TEAM; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84951779726     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.06.017     Document Type: Article

References (23)

1. Mozaffarian D., Benjamin E.J., Go A.S., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015, 131:e29-e322.
2. Peacock W.F., Costanzo M.R., De Marco T., et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 2009, 113:12-19.
3. Hebert K., Dias A., Franco E., Tamariz L., Steen D., Arcement L.M. Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program. Congest Heart Fail 2011, 17:309-313.
4. Ryder M., Murphy N.F., McCaffrey D., O'Loughlin C., Ledwidge M., McDonald K. Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail 2008, 10:267-272.
5. Lazkani M., Ota K.S. The role of outpatient intravenous diuretic therapy in a transitional care progam for patients with heart failure: a case series. J Clin Med Res 2012, 4:434-438.
6. Makadia S., Simmons T., Augustine S., et al. A new cost effective strategy for the outpatient management of heart failure. Am J Med 2015, 128:527-531.
7. Schipper J., Domingo G., Dickson V., Katz S. Implementation of tailored intravenous heart failure therapy in a non-dedicated outpatient infusion center. J Card Fail 2012, 18(Suppl):104.
8. Durango L., Katz S., Li H.-K., Wencker D. Continuous furosemide infusion is safe and effective in outpatient treatment of refractory heart failure (abstr.). Circulation 2006, 114:375-376.
9. Felker G.M., Lee K.L., Bull D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011, 364:797-805.
10. Salvador D.R.K., Punzalan F.E., Ramos G.C. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005, 3:1-3.
11. Barsuk J.H., Gordon R.A., Cohen E.R., et al. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure. Congest Heart Fail 2013, 19:53-60.
12. Felker G.M., Mentz R.J. Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 2012, 59:2145-2153.
13. Weintraub N.L., Collins S.P., Pang P.S., et al. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation 2010, 122:1975-1996.
14. Rame J.E., Sheffield M.A., Dries D.L., et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J 2001, 142:714-719.
15. Gheorghiade M., Pang P.S., Ambrosy A.P., et al. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev 2012, 17:485-509.
16. Collins S.P., Pang P.S., Fonarow G.C., Yancy C.W., Bonow R.O., Gheorghiade M. Is hospital admission for heart failure really necessary? The role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol 2013, 61:121-126.
17. Bikdeli B., Strait K.M., Dharmarajan K., et al. Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?. J Am Coll Cardiol 2013, 61:1549-1550.
18. Buggey J., Mentz R.J., Pitt B., et al. A reappraisal of loop diuretic choice in heart failure patients. Am Heart J 2015, 169:323-333.
19. Patel C.B., DeVore A.D., Felker G.M., et al. Characteristics and outcomes of patients with heart failure and discordant findings by right-sided heart catheterization and cardiopulmonary exercise testing. Am J Cardiol 2014, 114:1059-1064.
20. Kittleson M., Hurwitz S., Shah M.R., et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 2003, 41:2029-2035.
21. Costanzo M.R., Mills R.M., Wynne J. Characteristics of "Stage D" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). Am Heart J 2008, 155:339-347.
22. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
23. Borlaug B.A., Kass D.A. Ventricular-vascular interaction in heart failure. Heart Fail Clin 2008, 4:23-36.